Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Gastrointestinal 5Breast 5Other hematologic neoplasm 4Sarcoma 2Plasma cell 2Genitourinary 2Myeloid 1Gynecologic 1Classical hematology 1CNS 1

Conditions

Thrombocytopenia 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Cyclophosphamide 36fludarabine phosphate 34Mycophenolic Acid 32Whole-Body Irradiation 31Busulfan 24fludarabine 21Tacrolimus 21Cyclosporine 20Peripheral Blood Stem Cell Transplantation 19Melphalan 17Antilymphocyte Serum 13Filgrastim 12Methotrexate 11Granulocyte Colony-Stimulating Factor 11Cytarabine 11Cord Blood Stem Cell Transplantation 11thymoglobulin 8eltrombopag 8Thiotepa 8Lenalidomide 7Etoposide 7Epoetin Alfa 7Dalteparin 7romiplostim 6Darbepoetin alfa 6Alemtuzumab 6apixaban 5Sirolimus 5Radiotherapy 5Cyclosporins 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Microarray Analysis × Classical hematology × Clear all
NCT01165996 2019-03-04

Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome

Case Comprehensive Cancer Center

Phase 1/2 Completed
25 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡